Hematology Special Issue 2018
CAR-T Cell Therapy: What We Never Dreamed Of
March 11th 2018Never in their wildest dreams dreams would immunologists from the last generation have imagined chimeric antigen receptor (CAR)-T cell therapy coming to light. The very notion of genetically engineering a T cell to recognize a tumor antigen would have been viewed almost as a pipe dream.
Patients with MPNs Willing to Alter Diet, Supplement Use to Alleviate Symptoms
March 6th 2018Nutritional change may be a potential strategy to improve symptom burden and inflammation in patients with MPNs, whohave increased inflammatory cytokines, which contribute to symptoms such as fatigue, night sweats and bone pain, as well as low cholesterol and weight loss related to nutritional deficiencies.
After 40 Years, Acute Myeloid Leukemia Gets 4 New Treatments
March 2nd 2018FOR THE FIRST TIME in more than 40 years, patients with acute myeloid leukemia (AML) have reason to hope. After years of little to no improvement, four new agents were approved in the same year bringing huge advancements to the field.
